Department of Psychology, American College of Greece - Deree, 6 Gravias Street GR-153 42 Aghia Paraskevi, Athens, Greece.
First Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 74 Vas. Sofias Ave, 11528, Athens, Greece.
Syst Rev. 2021 Aug 30;10(1):239. doi: 10.1186/s13643-021-01788-1.
Adolescence and young adulthood is a risk period for the emergence of mental disorders. There is strong evidence that psychotherapeutic interventions are effective for most mental disorders. However, very little is known about which of the different psychotherapeutic treatment modalities are effective for whom. This large systematic review aims to address this critical gap within the literature on non-specific predictors and moderators of the outcomes of psychotherapeutic interventions among adolescents and young adults with mental disorders.
The protocol is being reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) Statement. PubMed and PsycINFO databases will be searched for randomized controlled and quasi-experimental/naturalistic clinical trials. Risk of bias of all included studies will be assessed by the Mixed Methods Appraisal Tool. The quality of predictor and moderator variables will be also assessed. A narrative synthesis will be conducted for all included studies.
This systematic review will strengthen the evidence base on effective mental health interventions for young people, being the first to explore predictors and moderators of outcome of psychotherapeutic interventions for a wide range of mental disorders in young people.
PROSPERO CRD42020166756 .
青少年和青年期是出现精神障碍的风险期。有强有力的证据表明，心理治疗干预对大多数精神障碍都是有效的。然而，对于哪些不同的心理治疗方法对哪些人有效，我们知之甚少。这项大型系统评价旨在解决精神障碍青少年和青年心理治疗干预结果的非特异性预测因子和调节因子文献中的这一关键差距。
本方案按照系统评价和荟萃分析方案的首选报告项目（PRISMA-P）声明进行报告。将在 PubMed 和 PsycINFO 数据库中搜索随机对照和准实验/自然临床试验。将使用混合方法评估工具评估所有纳入研究的偏倚风险。还将对预测因子和调节变量的质量进行评估。将对所有纳入的研究进行叙述性综合。
这项系统评价将加强针对年轻人的有效心理健康干预措施的证据基础，这是第一个探索针对年轻人广泛的精神障碍的心理治疗干预结果的预测因子和调节因子的研究。
PROSPERO CRD42020166756。
